1. Home
  2. NTRA vs ROL Comparison

NTRA vs ROL Comparison

Compare NTRA & ROL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • ROL
  • Stock Information
  • Founded
  • NTRA 2003
  • ROL 1948
  • Country
  • NTRA United States
  • ROL United States
  • Employees
  • NTRA N/A
  • ROL N/A
  • Industry
  • NTRA Medical Specialities
  • ROL Diversified Commercial Services
  • Sector
  • NTRA Health Care
  • ROL Finance
  • Exchange
  • NTRA Nasdaq
  • ROL Nasdaq
  • Market Cap
  • NTRA 24.9B
  • ROL 26.9B
  • IPO Year
  • NTRA 2015
  • ROL N/A
  • Fundamental
  • Price
  • NTRA $192.81
  • ROL $53.87
  • Analyst Decision
  • NTRA Strong Buy
  • ROL Buy
  • Analyst Count
  • NTRA 17
  • ROL 9
  • Target Price
  • NTRA $196.24
  • ROL $61.44
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • ROL 1.7M
  • Earning Date
  • NTRA 11-07-2025
  • ROL 10-29-2025
  • Dividend Yield
  • NTRA N/A
  • ROL 1.23%
  • EPS Growth
  • NTRA N/A
  • ROL 9.81
  • EPS
  • NTRA N/A
  • ROL 1.06
  • Revenue
  • NTRA $1,964,250,000.00
  • ROL $3,680,306,000.00
  • Revenue This Year
  • NTRA $24.17
  • ROL $12.34
  • Revenue Next Year
  • NTRA $15.57
  • ROL $8.88
  • P/E Ratio
  • NTRA N/A
  • ROL $50.59
  • Revenue Growth
  • NTRA 44.38
  • ROL 11.17
  • 52 Week Low
  • NTRA $119.29
  • ROL $45.34
  • 52 Week High
  • NTRA $198.99
  • ROL $59.12
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 68.54
  • ROL 32.72
  • Support Level
  • NTRA $183.88
  • ROL $54.74
  • Resistance Level
  • NTRA $198.99
  • ROL $57.48
  • Average True Range (ATR)
  • NTRA 6.55
  • ROL 1.14
  • MACD
  • NTRA 1.09
  • ROL -0.19
  • Stochastic Oscillator
  • NTRA 80.07
  • ROL 3.48

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.

Share on Social Networks: